Nabriva Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Nabriva Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 31% to $35,668,000. Profit margin reached -160%. Total operating expenses were $58,260,000.
Profit Margin
| 2013 | 0 | 15.47M | |
|---|---|---|---|
| 2014 | 0 | -16.27M | |
| 2015 | 84K | -31.38M | -37364.91% |
| 2016 | 0 | -54.89M | |
| 2017 | 0 | -74.35M | |
| 2018 | 6.5M | -114.78M | -1765.85% |
| 2019 | 7.74M | -82.76M | -1068.2% |
| 2020 | 2.86M | -69.48M | -2426.12% |
| 2021 | 27.21M | -49.45M | -181.69% |
| 2022 | 35.66M | -57.18M | -160.33% |
NBRV Income Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 35.66M | 27.21M | 2.86M | 7.74M | 6.5M | 0 | 0 | 84K | 0 | 0 |
Cost of revenue | 28.58M | 13.14M | 766K | 70K | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 7.08M | 14.06M | 2.09M | 7.67M | 6.5M | 0 | 0 | 84K | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 14.26M | 12.63M | 15.10M | 26.41M | 82.28M | 49.61M | 47.99M | 22.72M | 8.59M | 10.11M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 58.26M | 62.59M | 68.22M | 87.16M | 120.87M | 73.76M | 55.04M | 26.83M | 9.89M | 6.74M |
Operating income | -51.17M | -48.52M | -66.12M | -79.48M | -114.37M | -73.76M | -55.04M | -23.97M | -9.76M | 22.31M |
Other income (expenses), net | -4.44M | -432K | -3.21M | -3.17M | -272K | 767K | -783K | 2.85M | -6.41M | 28.53M |
Income before tax | -55.61M | -48.96M | -69.34M | -82.66M | -114.73M | -73.00M | -55.56M | -31.82M | -16.18M | 16.55M |
Income tax expense | 1.56M | 490K | 139K | 101K | 49K | 1.35M | -672K | -438.41K | 87.55K | 1.07M |
Net income | -57.18M | -49.45M | -69.48M | -82.76M | -114.78M | -74.35M | -54.89M | -31.38M | -16.27M | 15.47M |
Earnings per share | ||||||||||
Basic EPS | -21.32 | -28.52 | -135.23 | -278.86 | -564.91 | -623.15 | -638.9 | -741.38 | -149.52 | 142.25 |
Diluted EPS | -21.32 | -28.52 | -135.23 | -278.86 | -564.91 | -623.15 | -638.9 | -741.38 | -149.52 | 130.92 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |